Everything we do starts and ends with what patients value, but it is a continuous journey. Starting with the patient keeping them at the heart of everything we do. Read More
Read the latest news from the MassBio community! This space is for members to share company updates and press releases. Members may not post stories that are copyrighted by news publications or post sales pitches.
Life Science Cares & The Possible Project,challenge local companies to donate 1,000 used laptop computers to We Sell Possible program. Read More
President Trump and U.S. Department of Health and Human Services (HHS) Secretary Alex Azar delivered highly anticipated speeches regarding the Administration's plan to reduce drug prices. Read More
Asymmetrex co-sponsors Nov. 30 online RegMedNet expert panel on the state of knowledge for production and characterization of tissue stem cells used in approved therapies and experimental treatments. Read More
Seyfarth Shaw LLP announced today that Dean Fanelli, Ph.D. and Thomas Haag, Ph.D., co-founders of top intellectual property boutique Fanelli Haag PLLC, have joined Seyfarth as partners in the Litigati Read More
MA stem cell biotech company Asymmetrex proposes that its new technology for certifying the specific dose and quality of tissue stem cells used in experimental treatments would improve FDA’s efforts. Read More
Join Gradient for a Free Webinar on Thursday, October 12, 2017, from 1:00-2:00 PM ET Read More